We are live on ! Find out more
ALXA

Alexza Pharmaceuticals Inc
ALXA

Delisted

ALXA was delisted on the 16th of June, 2016.

26 hedge funds and large institutions have $3.5M invested in Alexza Pharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

8% more funds holding

Funds holding: 2426 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

44% less capital invested

Capital invested by funds: $6.21M → $3.5M (-$2.71M)

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
6
Reduced
5
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
IA
26
IFP Advisors
Florida
+$413 +400 New
Citigroup
27
Citigroup
New York
+$629 +610 New

ALXA Hedge Fund Activity: Q4 2015 in Review

26 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q4 2015, worth a combined $3.5M — down 44% from $6.21M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ALXA positions and 4 closed out — a net gain of 2 holders — while 6 added to existing stakes and 5 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $37.5K. The largest seller was Howard Hughes Medical Institute, exiting entirely with an estimated $122K sold.

  • 26 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q4 2015, up from 24 in Q3 2015.
  • Funds reported $3.5M of Alexza Pharmaceuticals Inc stock for Q4 2015, down 44% quarter-over-quarter.
  • 6 funds opened new Alexza Pharmaceuticals Inc positions in Q4 2015 and 4 closed out, a net change of +2 holders.
  • The largest Alexza Pharmaceuticals Inc buyer in Q4 2015 was Susquehanna International Group, an estimated $37.5K added.
  • The largest Alexza Pharmaceuticals Inc seller in Q4 2015 was Howard Hughes Medical Institute, an estimated $122K sold.

Based on aggregated 13F filings for Q4 2015.